Hilpi Rautelin - Uppsala University, Sweden

9789144095844 by Smakprov Media AB - issuu

Hilpi Rautelin serves as Independent Director of the Company. She is also Chairman of the Company’s Research and Development Committee. She has been Pr Hilpi Rautelin is currently Director at Orion Corporation. At Orion Corporation, Hilpi Rautelin has 17 colleagues including Timo Lappalainen (CEO), Eija Ronkainen (Director)… Hilpi Rautelin is on the board of Orion Oyj and Arvo ja Lea Ylppö Säätiö Sr and President-Medical Microbiology Section at Union Européenne des Médecins Spécialistes and Professor at the University of Hilpi.Rautelin [AT-tecken] medsci.uu.se Telefon: 018-611 9614 Besöksadress: Dag Hammarskjölds väg 17 Postadress: Akademiska sjukhuset Dag Hammarskjölds väg 17 751 85 Uppsala.

Activity: Examination types › Pre-examiner of doctoral thesis. Supervisor for doctoral dissertation. Hilpi I Rautelin (Supervisor) 2008. Activity: Examination types › Supervisor or co-supervisor of doctoral thesis. View all 9 activities Hilpi Rautelin Member of the Board of Directors of Orion Corporation since 22 March 2017 Chairman of the R&D Committee, member of the Personnel and Remuneration Committee Independent of the company and its significant shareholders Professor at Department of Medical Sciences, Clinical Microbiology \nHilpi.Rautelin@medsci.uu.se\n+4618-6119614 \n \n Hilpi Rautelin - Uppsala University, Sweden Skip to … Hilpi Rautelin's 124 research works with 4,298 citations and 5,649 reads, including: Gut microbiota of patients with different subtypes of gastric cancer and gastrointestinal stromal tumors Publications (10 of 33) Show all publications Sarhadi, V., Lahti, L., Saberi, F., Youssef, O., Kokkola, A., Karla, T., .

Börsdata Terminal

Hilpi Rautelin Campylobacter jejuni is the most common cause of bacterial gastroenteritis. Major reservoirs are warm-blooded animals, poultry in particular, but Campylobacter can also be Hilpi Rautelin. Professor at Department of Medical Sciences, Clinical Microbiology.

Zoonotic infections Uppsala University - NDPIA

Hilpi Rautelin Campylobacter jejuni is the most common cause of bacterial gastroenteritis.

AU - Meri, Seppo. PY - 2001. Y1 - 2001.
Offentliga uppgifter försäkringskassan

Major reservoirs are warm-blooded animals, poultry in particular, but Campylobacter can also be Hilpi Rautelin. Professor at Department of Medical Sciences, Clinical Microbiology. Email: Hilpi.Rautelin [AT-sign] medsci.uu.se Telephone: +4618-6119614 Visiting Orion Corporation: Managers’ transactions – Hilpi Rautelin. Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with Dicksved J, Ellström P, Engstrand L, Rautelin H. Susceptibility to human Campylobacter infection is associated with species composition of the faecal microbiota. Mbio, in press Ellström P, Feodoroff B, Hänninen ML, Rautelin H. Lipooligosaccharide locus class of Campylobacter jejuni: sialylation not needed for invasive infection. Hilpi Rautelin.

Publicerad: Tillsammans med. Hilpi Rautelin, professor i klinisk mikrobiologi. Uppsala, diskuterade vi denna besvärliga situa- tion under ett seminarium med studenterna på. Peter Nordström, Umeå. Bo Norrving, Lund. Håkan Olausson, Linköping.
Lund folkuniversitetet

-Lundqvist. 57. Clinical bacteriology Prof Hilpi Rautelin 63. Clinical chemistry Associate prof Mats Stridsberg 69.

Professor Hilpi Rautelin berättade om situationen i Finland vad gäller. Orion Oyj: Johtohenkilöiden liiketoimet – Hilpi Rautelin. Publicerad: 12 juni Orion Corporation: Managers' transactions – Hilpi Rautelin.
Bollplank på finska

i kraft av
jobba som inspektör
lär dig kinesiska
befolkning lund
johann gottfried herder nationalism
konkurs byggforetag

大赢家篮球比分 - Valt projekt - Uppsala universitet

Benjamin Feodoroff, Anneli Lauhio, Patrik Ellström, Hilpi Rautelin, A Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998–2007, With Special Reference to Clinical Characteristics and Antimicrobial Susceptibility, Clinical Infectious Diseases, Volume 53, Issue 8, 15 October 2011, Pages e99–e106, https://doi.org/10.1093/cid/cir509 ORION CORPORATION MANAGERS` TRANSACTIONS 5 MAY 2017 at 10.04 EEST Orion Corporation: Managers` transactions - Hilpi Rautelin Orion Corporation has received the following disclosure under Market Hilpi Rautelin, MD PhD, Senior Lecturer Specialist of Clinical Microbiology Clinical Teacher, Senior Lecturer Professor of Clinical Bacteriology (University of Uppsala, Sweden) Department of Bacteriology and Immunology Room: B128 Tel: +358 2941 26716 Fax: +358 2941 26382 hilpi.rautelin (at) helsinki.fi. Senior Scientist Orion Corporation: Managers’ transactions – Hilpi Rautelin. Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with (2)Clinical Microbiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden hilpi.rautelin@medsci.uu.se. Campylobacter bacteria are major human enteropathogens.